Jiangsu Hengrui Pharmaceuticals Co.,Ltd (SHA:600276)
China flag China · Delayed Price · Currency is CNY
57.24
+1.12 (2.00%)
Apr 8, 2026, 11:29 AM CST

SHA:600276 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
40,95524,81620,74615,11113,631
Trading Asset Securities
113.84273.3499.052,7605,090
Cash & Short-Term Investments
41,06925,08920,84517,87118,721
Cash Growth
63.69%20.36%16.64%-4.54%13.93%
Accounts Receivable
5,9096,1596,1358,3416,884
Other Receivables
28.1766.41438.25562.18658
Receivables
5,9386,2266,5738,9047,542
Inventory
2,8782,4172,3142,4512,403
Prepaid Expenses
166.79239.54226.07507.2431.57
Other Current Assets
1,4381,3431,3291,2011,090
Total Current Assets
51,49035,31531,28730,93430,188
Property, Plant & Equipment
7,9086,9286,6296,6766,276
Long-Term Investments
2,0301,7321,4511,5081,001
Other Intangible Assets
1,9561,192883.77519.9442.45
Long-Term Deferred Tax Assets
780.96377.17320.56238.9141.36
Long-Term Deferred Charges
5,0904,1122,8292,052569.38
Other Long-Term Assets
611.69479.11383.3442.55648.99
Total Assets
69,86750,13643,78542,37139,266
Accounts Payable
1,9951,5171,3341,4931,920
Accrued Expenses
1,405941.05578.8597.57165.66
Short-Term Debt
---1,261-
Current Portion of Leases
30.9341.13---
Current Income Taxes Payable
633.05242.9459.284.0321.77
Current Unearned Revenue
1,913159.79198.09187.08219.55
Other Current Liabilities
392.96731.36383.42596.131,074
Total Current Liabilities
6,3693,6342,5543,6393,402
Long-Term Leases
43.3169.0475.1898.86151.59
Long-Term Unearned Revenue
1,541225.6538.95119.44116.52
Long-Term Deferred Tax Liabilities
116.96117.1183.64100.4524.77
Total Liabilities
8,0704,0452,7513,9583,694
Common Stock
6,6376,3796,3796,3796,396
Additional Paid-In Capital
12,9353,1883,0583,0203,356
Retained Earnings
43,60137,16432,10228,81925,928
Treasury Stock
-1,929-1,229-1,092-398.03-664.94
Comprehensive Income & Other
27.9616.9719.323.23-12.16
Total Common Equity
61,27245,52040,46637,82435,003
Minority Interest
524.75570.39567.29589.35568.85
Shareholders' Equity
61,79746,09041,03338,41335,572
Total Liabilities & Equity
69,86750,13643,78542,37139,266
Total Debt
74.23110.1675.181,360151.59
Net Cash (Debt)
40,99524,97920,77016,51118,570
Net Cash Growth
64.12%20.27%25.79%-11.08%13.00%
Net Cash Per Share
6.273.943.282.582.91
Filing Date Shares Outstanding
6,5346,3626,3616,3676,382
Total Common Shares Outstanding
6,5346,3626,3616,3676,382
Working Capital
45,12131,68128,73427,29526,786
Book Value Per Share
9.387.166.365.945.48
Tangible Book Value
59,31644,32839,58237,30434,561
Tangible Book Value Per Share
9.086.976.225.865.42
Buildings
4,8923,9753,8543,5412,700
Machinery
6,5236,1045,9695,6845,120
Construction In Progress
2,0061,6881,1011,1931,659
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.